AU2022246161A1 - Rifamycin analogs in combination with vancomycin and uses thereof - Google Patents

Rifamycin analogs in combination with vancomycin and uses thereof Download PDF

Info

Publication number
AU2022246161A1
AU2022246161A1 AU2022246161A AU2022246161A AU2022246161A1 AU 2022246161 A1 AU2022246161 A1 AU 2022246161A1 AU 2022246161 A AU2022246161 A AU 2022246161A AU 2022246161 A AU2022246161 A AU 2022246161A AU 2022246161 A1 AU2022246161 A1 AU 2022246161A1
Authority
AU
Australia
Prior art keywords
pharmaceutically acceptable
acceptable salt
vancomycin
compound
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2022246161A
Other languages
English (en)
Inventor
Thomas Nittoli
Anna ZUMSTEG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regeneron Pharmaceuticals Inc
Original Assignee
Regeneron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals Inc filed Critical Regeneron Pharmaceuticals Inc
Publication of AU2022246161A1 publication Critical patent/AU2022246161A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2022246161A 2021-03-26 2022-03-25 Rifamycin analogs in combination with vancomycin and uses thereof Abandoned AU2022246161A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163166597P 2021-03-26 2021-03-26
US63/166,597 2021-03-26
PCT/US2022/021922 WO2022204499A1 (en) 2021-03-26 2022-03-25 Rifamycin analogs in combination with vancomycin and uses thereof

Publications (1)

Publication Number Publication Date
AU2022246161A1 true AU2022246161A1 (en) 2023-10-12

Family

ID=81308077

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022246161A Abandoned AU2022246161A1 (en) 2021-03-26 2022-03-25 Rifamycin analogs in combination with vancomycin and uses thereof

Country Status (14)

Country Link
US (1) US20240189319A1 (https=)
EP (1) EP4313060B1 (https=)
JP (1) JP2024511165A (https=)
KR (1) KR20230162654A (https=)
CN (1) CN117098540A (https=)
AU (1) AU2022246161A1 (https=)
BR (1) BR112023019720A2 (https=)
CA (1) CA3213382A1 (https=)
CL (1) CL2023002840A1 (https=)
CO (1) CO2023013406A2 (https=)
ES (1) ES3017798T3 (https=)
IL (1) IL307220A (https=)
MX (1) MX2023011328A (https=)
WO (1) WO2022204499A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024221162A1 (zh) * 2023-04-24 2024-10-31 丹诺医药(苏州）有限公司 化合物预防关节假体周围感染的方法
KR20260012505A (ko) 2024-07-18 2026-01-27 이화여자대학교 산학협력단 기계 학습을 이용한 반코마이신 초회 투여량 적합성 판단 시스템 및 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118955710A (zh) * 2018-05-09 2024-11-15 里珍纳龙药品有限公司 抗msr1抗体及其使用方法
PH12021551476A1 (en) * 2018-12-21 2022-04-25 Regeneron Pharma Rifamycin analogs and antibody-drug conjugates thereof

Also Published As

Publication number Publication date
US20240189319A1 (en) 2024-06-13
CN117098540A (zh) 2023-11-21
BR112023019720A2 (pt) 2024-01-23
CO2023013406A2 (es) 2023-10-30
KR20230162654A (ko) 2023-11-28
ES3017798T3 (en) 2025-05-13
CA3213382A1 (en) 2022-09-29
WO2022204499A1 (en) 2022-09-29
MX2023011328A (es) 2023-12-14
CL2023002840A1 (es) 2024-03-15
EP4313060A1 (en) 2024-02-07
IL307220A (en) 2023-11-01
JP2024511165A (ja) 2024-03-12
EP4313060B1 (en) 2025-03-05

Similar Documents

Publication Publication Date Title
AU2012310136B2 (en) Nitrogen containing compounds and their use
CN101553470A (zh) 抗菌的喹啉衍生物
JP5961177B2 (ja) 化合物及びその使用
EP4313060B1 (en) Rifamycin analogs in combination with vancomycin and uses thereof
CN108658991B (zh) 3,5-二取代甲基吡唑并[1,5-a]嘧啶-7-酚盐类似物和衍生物制备方法和用途
CN108368079A (zh) 治疗细菌感染的化合物及方法
WO2011113361A1 (zh) 头孢唑肟钠结晶水合物及其制备方法和用途
CN101232884A (zh) 作为抗菌剂的喹啉衍生物
CN111787921A (zh) 锌离子载体及其用途
CN106414444A (zh) 含氮化合物以及它们的用途
CA2924733A1 (en) Aryl substituted aminomethyl spectinomycin analogs as antibacterial agents
WO2018045313A1 (en) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase
HK40105351A (en) Rifamycin analogs in combination with vancomycin and uses thereof
HK40105351B (en) Rifamycin analogs in combination with vancomycin and uses thereof
CN101541752A (zh) 抗菌的喹啉衍生物
CN104981238B (zh) 抗细菌化合物
EP4406952A1 (en) New compounds for treating staphylococcus infections
NZ618286B2 (en) Nitrogen containing compounds suitable for preventing or treating bacterial infections
HK1122210B (en) Quinoline derivatives as antibacterial agents

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period